GET THE APP

Comparative In Silico Docking Study Involving Antagonistic Activity of Coumarin Derivatives on EGFR and CDK2 | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Comparative In Silico Docking Study Involving Antagonistic Activity of Coumarin Derivatives on EGFR and CDK2

Author(s): Nithin EU, Stebin Joseph, Asha Asokan Manakadan, Saranya TS

Epidemiological evidence suggests that about 25% of cancer occurs due to chronic inflammation, thus it is clear that cancer and inflammation are related [1]. Piroxicam is the one of the drug that is used in the treatment of both cancer and inflammation, but it is having some side effects like constipation, blurring of vision, skin rashes etc., Coumarin is having both anti-inflammatory and anti-cancer activity [2,3], so the purpose of this study is to screen the best target among Epidermal Growth Factor Receptor (EGFR) and Cyclin-dependent Kinase-2 (CDK2). Docking analysis was carried out using Argus lab 4.0.1. From the study it was found that EGFR showed better result compare to CDK2. Also methyl substitution at 8th position and chlorine substitution at 5th position of coumarin showed better activity than standard drug piroxicam and phytoconstituents isofraxidin and scopoletin.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 15261

Der Pharma Chemica received 15261 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry